Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study.

echocardiography nailfold capillaroscopy pulmonary arterial hypertension right heart catheterization systemic sclerosis

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 20 04 2022
accepted: 22 06 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Systemic sclerosis (SSc) is a connective tissue disease characterized by immune-system alterations, fibrosis involving the skin and internal organs and diffuse microangiopathy. Pulmonary arterial hypertension (PAH) is a severe complication of SSc affecting about 10-15% of the patients and it is a leading cause of mortality. Due to the devastating nature of SSc-PAH, there is a clear need to systematically adopt appropriate screening programs. Nail fold videocapillaroscopy (NVC) studies have shown a more severe peripheral microvascular dysfunction in SSc patients with PAH suggesting that abnormalities in peripheral microcirculation may correlate with pulmonary microangiopathy. This is a cross-sectional study involving four tertiary University Rheumatology Units in the Center-North of Italy. Seventy patients, 35 adults with SSc and PAH confirmed by RHC (F/M 34/1; median age 65.2 ± 8.9 SD yrs), and 35 SSc patients without PAH were enrolled (F/M 3471; median age 63.3 ± 10.3 SD yrs). Clinical, laboratoristic and instrumental data were collected and NVC was performed in all patient. Specific NVC parameters were evaluated and a semi-quantitative rating scale was adopted to score these changes. Finally, patients were distributed into the suitable NVC pattern belonging to the scleroderma pattern. Our aim was to compare the peripheral microangiopathy changes in SSc patients with and without PAH, and to investigate the relationship between NVC findings and the main hemodynamic parameters of pulmonary vasculopathy. Patients with SSc-PAH+ showed a significant higher frequency of interstitial lung disease (ILD). No significant differences regarding clinical and laboratoristic parameters were observed. NVC abnormalities, avascular areas were more frequent in SSc patients with PAH, respect to those without (

Identifiants

pubmed: 35898279
doi: 10.3389/fcvm.2022.924899
pmc: PMC9309490
doi:

Types de publication

Journal Article

Langues

eng

Pagination

924899

Informations de copyright

Copyright © 2022 Giuggioli, Riccieri, Cipolletta, Del Papa, Ingegnoli, Spinella, Pellegrino, Risa, de Pinto, Papa, Armentaro and De Angelis.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Rheumatol. 2022 Feb;49(2):176-185
pubmed: 34782448
J Clin Med. 2021 Apr 06;10(7):
pubmed: 33917407
Intern Emerg Med. 2015 Oct;10(7):823-30
pubmed: 26037393
Autoimmun Rev. 2020 Mar;19(3):102458
pubmed: 31927087
Microvasc Res. 2017 Nov;114:46-51
pubmed: 28619664
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Arthritis Res Ther. 2020 Oct 13;22(1):237
pubmed: 33050944
Eur Respir Rev. 2019 Jul 31;28(153):
pubmed: 31366460
Semin Arthritis Rheum. 2017 Aug;47(1):86-94
pubmed: 28291582
Rheumatology (Oxford). 2013 Aug;52(8):1525-8
pubmed: 23671125
Pulm Circ. 2011 Apr-Jun;1(2):138-59
pubmed: 22034603
Respir Res. 2021 Jan 21;22(1):27
pubmed: 33478514
J Rheumatol. 2020 Jun 1;47(6):888-895
pubmed: 31416927
Rheumatology (Oxford). 2017 Jan;56(1):14-25
pubmed: 27094599
Dis Model Mech. 2010 May-Jun;3(5-6):268-73
pubmed: 20427556
Pharmaceuticals (Basel). 2021 Apr 23;14(5):
pubmed: 33922710
Ann Rheum Dis. 2010 Oct;69(10):1809-15
pubmed: 20551155
Ann Rheum Dis. 2009 Feb;68(2):191-5
pubmed: 18375538
Arthritis Rheum. 2011 Nov;63(11):3522-30
pubmed: 21769843
Microvasc Res. 2013 Sep;89:122-8
pubmed: 23792167
Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101683
pubmed: 33814313
J Rheumatol. 2012 Jun;39(6):1248-55
pubmed: 22467924
Rheumatology (Oxford). 2020 May 1;59(5):1051-1058
pubmed: 31750929
J Autoimmun. 2021 Nov;124:102727
pubmed: 34601207
Intern Med J. 2018 Nov;48(11):1355-1359
pubmed: 29761614
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Pharmacol Rev. 2012 Jul;64(3):583-620
pubmed: 22659328
Scand J Rheumatol. 2021 Mar;50(2):85-94
pubmed: 32909481
Reumatismo. 2021 Jan 18;72(4):228-246
pubmed: 33677950
Intern Med J. 2009 Oct;39(10):682-91
pubmed: 19220532
Ann Rheum Dis. 2017 Nov;76(11):1897-1905
pubmed: 28835464
Arthritis Rheum. 2012 Mar;64(3):821-5
pubmed: 22127901
Rheumatology (Oxford). 2012 Jun;51(6):1017-26
pubmed: 21900368
Ann Rheum Dis. 2007 Jul;66(7):940-4
pubmed: 17329309
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Clin Rev Allergy Immunol. 2011 Apr;40(2):78-83
pubmed: 20143182

Auteurs

Dilia Giuggioli (D)

Scleroderma Unit, Rheumatology Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.

Valeria Riccieri (V)

Scleroderma Clinic, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.

Edoardo Cipolletta (E)

Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

Nicoletta Del Papa (N)

Clinical Rheumatology Unit, ASST Pini-CTO, Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Italy.

Francesca Ingegnoli (F)

Clinical Rheumatology Unit, ASST Pini-CTO, Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Italy.

Amelia Spinella (A)

Scleroderma Unit, Rheumatology Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.

Greta Pellegrino (G)

Scleroderma Clinic, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.

Anna Maria Risa (AM)

Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

Marco de Pinto (M)

Scleroderma Unit, Rheumatology Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.

Silvia Papa (S)

Scleroderma Clinic, Rheumatology Unit, Sapienza University of Rome, Rome, Italy.

Giuseppe Armentaro (G)

Clinical Rheumatology Unit, ASST Pini-CTO, Department of Clinical Science and Community Health, Università degli Studi di Milano, Milan, Italy.

Rossella De Angelis (R)

Rheumatology Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.

Classifications MeSH